Insulin controls hyperglycemia caused by diabetes, and virtually all treatments require exogenous insulin. However, the product’s extensive post-translational modifications have hindered the manufacture of recombinant insulin. | Intein-mediated recombinant expression of monomeric B22Asp desB30 insulin